Crossmark

Analysis of belimumab prescription and outcomes in a 10-year monocentric cohort: is there an advantage with early use?

Crossref DOI link: https://doi.org/10.1136/rmdopen-2023-003981

Published Online: 2024-04-12

Published Print: 2024-04

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Tani, Chiara https://orcid.org/0000-0002-0870-8738
Zucchi, Dina https://orcid.org/0000-0002-2161-2562
Cardelli, Chiara https://orcid.org/0000-0001-6407-6213
Elefante, Elena https://orcid.org/0000-0003-0657-485X
Signorini, Viola

Schilirò, Davide

Cascarano, Giancarlo

Gualtieri, Luca

Valevich, Anastasiya

Puccetti, Giulia

Carli, Linda

Stagnaro, Chiara

Mosca, Marta
License Information

License valid from 2024-04-12